BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, February 11, 2026
Home
»
Newsletters
» BioWorld MedTech
BioWorld MedTech
April 14, 2014
View Archived Issues
New Boston Sci registry to evaluate Vercise DBS in Parkinson's patients
Boston Scientific (Natick, Massachusetts) has enrolled the first patient in a new registry to evaluate clinical outcomes and the economic value of the Vercise deep brain stimulation (DBS) system in patients with Parkinson's disease.
Read More
Report from Israel: Nazareth incubator NGT3 raising funds with lofty dual agenda
Read More
Washington Roundup: FDA nod to Block HF adds 800K to market for biventricular pacing
Read More
MDD's Stock Watch
Read More
Report from Europe: Focus shifts from sales to costs for French startups
Read More
Court Report: Varian settles patent litigation with University of Pittsburgh for $35M
Read More
Deals Roundup: Covidien in plan to acquire New Wave Surgical for $100M
Read More
Report from Europe: Seno awarded CE mark for Imagio imaging system
Read More
Financings roundup: Ventas prices public offering of senior notes
Read More
Sebelius out at HHS, but Burwell unlikely to steer different course
Read More
People in Places
Read More
Briefly Noted
Read More
Product briefs
Read More
MDD's Neurology Extra
Read More
